FBXO45 Knockdown Restrains the Progression of Bladder Cancer via the ERK/Cyclin D1/CDK4 Pathway.
Weiyang ZhangQingyuan LiuJindong ZhangDelin Wang
Published in: Archivos espanoles de urologia (2024)
plays a carcinogenic role in bladder cancer via the ERK/Cyclin D1/CDK4 pathway, which provides a reference for the clinical treatment of patients with bladder cancer.